Clot-busting meds may be effective up to 24 hours after initial stroke symptoms
The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...
EurekAlert!2d
UCalgary researchers confirm best approach for stroke in medium-sized blood vessels
University of Calgary researchers with the Calgary Stroke Program continue to advance the science to determine best ...
Medscape1d
Endovascular Therapy Fails to Show Benefit in Distal Occlusion Stroke
Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...
Your Gut and Oral Health Could Influence Your Stroke Risk, New Study Says—Here’s What to Know
It’s also important to get and maintain healthy gut and oral microbiomes. This involves eating plenty of fermented foods, ...
Daily1d
Routine colchicine administration after acute myocardial infarction may not improve outcomes, highlights study
The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term ...
TCTMD1d
Stroke Thrombectomy Doesn’t Help for Blockages in Smaller Vessels
Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.
Moscow-Pullman Daily News2d
Pullman Regional Hospital earns acute stroke ready recertification
The medical institution initially earned the certification in 2022, and is required to recertify annually. Pullman Regional ...
MassDevice1d
MicroTransponder Vivistim nerve stim tech delivers positive stroke outcomes
MicroTransponder recently announced positive real-world outcomes for its Vivistim vagus nerve stimulation (VNS) system.
TMCnet1d
Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference
(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world's first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system-the ...
Pharmabiz1d
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...